Stockscreener 앱 받기
0.00
100.00%
-0.0973
전일 마감가:
$0.0973
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$95.35M
수익:
$25.19M
순이익/손실:
$-34.53M
주가수익비율:
0.00
EPS:
-0.036
순현금흐름:
$-20.62M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$0.1952
조메디카 Stock (ZOM) Company Profile
명칭
Zomedica Corp
전화
734-369-2555
주소
100 Phoenix Drive, Suite 190, Ann Arbor, MI
ZOM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZOM
Zomedica Corp
|
0.00 | 95.35M | 25.19M | -34.53M | -20.62M | -0.036 |
|
ZTS
Zoetis Inc
|
150.91 | 65.46B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.18 | 46.11B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.84B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.29 | 16.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
293.46 | 12.81B | 2.76B | 1.11B | 898.10M | 22.77 |
조메디카 Stock (ZOM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-06 | 개시 | Dawson James | Buy |
조메디카 주식(ZOM)의 최신 뉴스
Press Release Distribution & PR Platform - ACCESS Newswire
Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System - ACCESS Newswire
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split - ACCESS Newswire
Zomedica Corp. (ZOMDF): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo Finance
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
Is Zomedica Corp. (ZOMDF) the Cheapest Stock Insiders Are Buying In March? - Insider Monkey
15 Cheapest Stocks Insiders Are Buying In March - Insider Monkey
Zscaler, Rocket Lab, American Tower, Intuit, and Zomedica: Insider Moves Unveiled! - TipRanks
Zomedica director Rodney Williams acquires $6,900 in stock By Investing.com - Investing.com Canada
Zomedica director Rodney Williams acquires $6,900 in stock - Investing.com
Zomedica’s CFO Jordan Scott acquires $18,600 in common stock By Investing.com - Investing.com Canada
Zomedica director Christopher MacLeod buys $8,437 in stock - Investing.com India
Zomedica’s CFO Jordan Scott acquires $18,600 in common stock - Investing.com
Zomedica director Christopher MacLeod buys $8,437 in stock By Investing.com - Investing.com Australia
Zomedica CEO Larry Heaton acquires $29,702 in common stock By Investing.com - Investing.com Canada
Zomedica senior vice president buys $48,998 in common stock By Investing.com - Investing.com India
Zomedica director Johnny Powers acquires $33,650 in common stock By Investing.com - Investing.com Australia
Zomedica director Williams acquires $6,900 in common stock By Investing.com - Investing.com Canada
Zomedica director Christopher MacLeod acquires $8,437 in stock - Investing.com India
Zomedica COO Blair Anthony K acquires $30,000 in common stock By Investing.com - Investing.com Australia
Zomedica director Christopher MacLeod acquires $8,437 in stock By Investing.com - Investing.com South Africa
Zomedica director Jeffrey Rowe buys $96,098 in stock By Investing.com - Investing.com South Africa
Zomedica director Johnny Powers acquires $33,650 in common stock - Investing.com
Zomedica COO Blair Anthony K acquires $30,000 in common stock - Investing.com
Zomedica CEO Larry Heaton acquires $29,702 in common stock - Investing.com
Zomedica director Jeffrey Rowe buys $96,098 in stock - Investing.com
Zomedica senior vice president buys $48,998 in common stock - Investing.com
Zomedica director Williams acquires $6,900 in common stock - Investing.com
Zomedica Reports Record Revenue and Strong Growth - TipRanks
Earnings call transcript: Zomedica Q4 2024 shows revenue growth - Investing.com India
Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth - ACCESS Newswire
Zomedica (ZOM) Expected to Announce Quarterly Earnings on Thursday - Defense World
Zomedica Transitions to OTCQB Market Following NYSE Delisting - TipRanks
Zomedica Corp. Announces Transition to OTCQB Venture Market - Herald Palladium
About Us - Financial Content
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - ACCESS Newswire
Zomedica Interview To Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire
조메디카 (ZOM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.57%
0.15%
자본화:
|
볼륨(24시간):